Shreyada N. Save
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Shreyada N. Save has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Shilpy Sharma
Department of Biotechnology Savitribai Phule Pune University Ganeshkhind Road Pune Maharashtra 411007 India
5 shared publications - Pinaki Talukdar
Department of Chemistry, Indian Institute of Science Education and Research Pune, Dr Homi Bhabha Road, Pashan, Pune 411008, Maharashtra, India
4 shared publications - Abhijith Kuttanamkuzhi
Department of Biology Indian Institute of Science Education and Research Pune Dr. Homi Bhabha Road, Pashan Pune Maharashtra 411008 India
3 shared publications - Mayurika Lahiri
Department of Biology, Indian Institute of Science Education and Research (IISER), Pune 411008, Maharashtra, India
3 shared publications - Abhishek Mondal
Leiden Institute of Chemistry Leiden University Leiden The Netherlands
2 shared publications - Jagannath Mondal
Tata Institute of Fundamental Research
2 shared publications
Latest Publications
- 26 August 2025
- Published by Wiley in Angewandte Chemie
- Vol. 137 (42)
Pyrrole‐Linked Benzimidazolyl Hydrazone Self‐Assembly Forms HCl Channels and Induces Apoptosis in Cancer Cells
Modulation of intracellular chloride ion concentration by artificially developed ion transporters has been known to induce apoptosis in cancer cells. However, most of these transporters cause harm to healthy cells as well, limiting their applicability in real biological systems. Here, we report a pyrrole‐linked benzimidazolyl‐hydrazone that self‐assembles to form a nanochannel assembly across the lipid bilayer, enabling the selective translocation of HCl, a system rarely reported in the literature. The channel shows an extraordinarily high HCl transport activity with an EC50 value as low as 0.016 mol%, relative to lipid. We demonstrate solid‐state evidence that compound 1 self‐assembles in the presence of HCl to produce organized arrays that include chloride‐filled and water‐filled channels. The formation of a stable HCl channel across the lipid bilayer membrane was verified through electrophysiological experiments, detailed molecular dynamics (MD) simulations, and quantum mechanical calculations. When tested in cellular systems, the compound showed pronounced toxicity toward cancerous cell lines while remaining relatively nontoxic to cell lines of non‐cancerous origin. Interestingly, compound 1 was also found to inhibit the growth and proliferation of MCF‐7‐derived 3D spheroids with higher efficiency when compared to the commercially available anticancer drug─doxorubicin (DOX).
- 26 August 2025
- Published by Wiley in Angewandte Chemie
- Vol. 137 (42)
Pyrrole‐Linked Benzimidazolyl Hydrazone Self‐Assembly Forms HCl Channels and Induces Apoptosis in Cancer Cells
Modulation of intracellular chloride ion concentration by artificially developed ion transporters has been known to induce apoptosis in cancer cells. However, most of these transporters cause harm to healthy cells as well, limiting their applicability in real biological systems. Here, we report a pyrrole‐linked benzimidazolyl‐hydrazone that self‐assembles to form a nanochannel assembly across the lipid bilayer, enabling the selective translocation of HCl, a system rarely reported in the literature. The channel shows an extraordinarily high HCl transport activity with an EC50 value as low as 0.016 mol%, relative to lipid. We demonstrate solid‐state evidence that compound 1 self‐assembles in the presence of HCl to produce organized arrays that include chloride‐filled and water‐filled channels. The formation of a stable HCl channel across the lipid bilayer membrane was verified through electrophysiological experiments, detailed molecular dynamics (MD) simulations, and quantum mechanical calculations. When tested in cellular systems, the compound showed pronounced toxicity toward cancerous cell lines while remaining relatively nontoxic to cell lines of non‐cancerous origin. Interestingly, compound 1 was also found to inhibit the growth and proliferation of MCF‐7‐derived 3D spheroids with higher efficiency when compared to the commercially available anticancer drug─doxorubicin (DOX).
- 26 August 2025
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 64 (42) , e202505019
Pyrrole‐Linked Benzimidazolyl Hydrazone Self‐Assembly Forms HCl Channels and Induces Apoptosis in Cancer Cells
Modulation of intracellular chloride ion concentration by artificially developed ion transporters has been known to induce apoptosis in cancer cells. However, most of these transporters cause harm to healthy cells as well, limiting their applicability in real biological systems. Here, we report a pyrrole‐linked benzimidazolyl‐hydrazone that self‐assembles to form a nanochannel assembly across the lipid bilayer, enabling the selective translocation of HCl, a system rarely reported in the literature. The channel shows an extraordinarily high HCl transport activity with an EC50 value as low as 0.016 mol%, relative to lipid. We demonstrate solid‐state evidence that compound 1 self‐assembles in the presence of HCl to produce organized arrays that include chloride‐filled and water‐filled channels. The formation of a stable HCl channel across the lipid bilayer membrane was verified through electrophysiological experiments, detailed molecular dynamics (MD) simulations, and quantum mechanical calculations. When tested in cellular systems, the compound showed pronounced toxicity toward cancerous cell lines while remaining relatively nontoxic to cell lines of non‐cancerous origin. Interestingly, compound 1 was also found to inhibit the growth and proliferation of MCF‐7‐derived 3D spheroids with higher efficiency when compared to the commercially available anticancer drug─doxorubicin (DOX).
- 26 August 2025
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 64 (42) , e202505019
Pyrrole‐Linked Benzimidazolyl Hydrazone Self‐Assembly Forms HCl Channels and Induces Apoptosis in Cancer Cells
Modulation of intracellular chloride ion concentration by artificially developed ion transporters has been known to induce apoptosis in cancer cells. However, most of these transporters cause harm to healthy cells as well, limiting their applicability in real biological systems. Here, we report a pyrrole‐linked benzimidazolyl‐hydrazone that self‐assembles to form a nanochannel assembly across the lipid bilayer, enabling the selective translocation of HCl, a system rarely reported in the literature. The channel shows an extraordinarily high HCl transport activity with an EC50 value as low as 0.016 mol%, relative to lipid. We demonstrate solid‐state evidence that compound 1 self‐assembles in the presence of HCl to produce organized arrays that include chloride‐filled and water‐filled channels. The formation of a stable HCl channel across the lipid bilayer membrane was verified through electrophysiological experiments, detailed molecular dynamics (MD) simulations, and quantum mechanical calculations. When tested in cellular systems, the compound showed pronounced toxicity toward cancerous cell lines while remaining relatively nontoxic to cell lines of non‐cancerous origin. Interestingly, compound 1 was also found to inhibit the growth and proliferation of MCF‐7‐derived 3D spheroids with higher efficiency when compared to the commercially available anticancer drug─doxorubicin (DOX).
- Open Access
- 27 May 2024
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 22 (24) , 4987-4992
Bisindole-based small molecules as transmembrane anion transporters and potential anticancer agents
Few synthetic ion transporters have been reported incorporating indole as the core moiety. We have developed a novel bisindole-based transporter capable of efficient transmembrane anion antiport. This system induced cytotoxicity in MCF-7 breast cancer cells via chloride ion homeostasis disruption and the associated ROS generation, mitochondrial membrane depolarization, and lysosomal deacidification.
- 27 May 2024
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 22 (24) , 4987-4992
Open AccessBisindole-based small molecules as transmembrane anion transporters and potential anticancer agents
Few synthetic ion transporters have been reported incorporating indole as the core moiety. We have developed a novel bisindole-based transporter capable of efficient transmembrane anion antiport. This system induced cytotoxicity in MCF-7 breast cancer cells via chloride ion homeostasis disruption and the associated ROS generation, mitochondrial membrane depolarization, and lysosomal deacidification.
- 9 August 2023
- Published by Wiley in Chemistry – A European Journal
- Vol. 29 (51) , e202301412
NAD(P)H:Quinone Acceptor Oxidoreductase 1 (NQO1) Activatable Salicylamide H+/Cl− Transporters
NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a detoxifying enzyme overexpressed in tumors, plays a key role in protecting cancer cells against oxidative stress and thus has been considered an attractive candidate for activating prodrug(s). Herein, we report the first use of NQO1 for the selective activation of ‘protransporter’ systems in cancer cells leading to the induction of apoptosis. Salicylamides, easily synthesizable small molecules, have been effectively used for efficient H+/Cl− symport across lipid membranes. The ion transport activity of salicylamides was efficiently abated by caging the OH group with NQO1 activatable quinones via either ether or ester linkage. The release of active transporters, following the reduction of quinone caged ‘protransporters’ by NQO1, was verified. Both the transporters and protransporters exhibited significant toxicity towards the MCF‐7 breast cancer line, mediated via the induction of oxidative stress, mitochondrial membrane depolarization, and lysosomal deacidification. Induction of cell death via intrinsic apoptotic pathway was verified by monitoring PARP1 cleavage.
- 9 August 2023
- Published by Wiley in Chemistry – A European Journal
- Vol. 29 (51) , e202301412
NAD(P)H:Quinone Acceptor Oxidoreductase 1 (NQO1) Activatable Salicylamide H+/Cl− Transporters
NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a detoxifying enzyme overexpressed in tumors, plays a key role in protecting cancer cells against oxidative stress and thus has been considered an attractive candidate for activating prodrug(s). Herein, we report the first use of NQO1 for the selective activation of ‘protransporter’ systems in cancer cells leading to the induction of apoptosis. Salicylamides, easily synthesizable small molecules, have been effectively used for efficient H+/Cl− symport across lipid membranes. The ion transport activity of salicylamides was efficiently abated by caging the OH group with NQO1 activatable quinones via either ether or ester linkage. The release of active transporters, following the reduction of quinone caged ‘protransporters’ by NQO1, was verified. Both the transporters and protransporters exhibited significant toxicity towards the MCF‐7 breast cancer line, mediated via the induction of oxidative stress, mitochondrial membrane depolarization, and lysosomal deacidification. Induction of cell death via intrinsic apoptotic pathway was verified by monitoring PARP1 cleavage.